136 related articles for article (PubMed ID: 11287832)
1. Human recombinant interferon-alpha2a and interferon-alphaA/D have different effects on bleomycin-induced lung injury.
Berkman N; Kremer S; Or R; Lossos IS; Christensen TG; Goldstein RH; Breuer R
Respiration; 2001; 68(2):169-77. PubMed ID: 11287832
[TBL] [Abstract][Full Text] [Related]
2. Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters.
Ben Yehuda A; Lossos IS; Or R; Ben Chetrit E; Goldstein RH; Conner MW; Breuer R
Pulm Pharmacol Ther; 1997; 10(1):61-5. PubMed ID: 9344834
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin-induced lung injury is enhanced by interferon-alpha.
Berkman N; Goldstein RH; Breuer R
Life Sci; 1997; 60(26):PL415-21. PubMed ID: 9199490
[TBL] [Abstract][Full Text] [Related]
4. The effect of suramin on bleomycin-induced lung injury.
Lossos IS; Izbicki G; Or R; Goldstein RH; Breuer R
Life Sci; 2000 Oct; 67(23):2873-81. PubMed ID: 11106002
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A upmodulates bleomycin-induced pulmonary fibrosis in BALB/c mice.
Lossos IS; Or R; Ginzburg V; Christensen TG; Mashriki Y; Breuer R
Respiration; 2002; 69(4):344-9. PubMed ID: 12169749
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of bleomycin-induced pulmonary injury by cyclosporin A.
Lossos IS; Or R; Goldstein RH; Conner MW; Breuer R
Exp Lung Res; 1996; 22(3):337-49. PubMed ID: 8792125
[TBL] [Abstract][Full Text] [Related]
7. The effect of enoxaparin on bleomycin-induced lung injury in mice.
Laxer U; Lossos IS; Gillis S; Or R; Christensen TG; Goldstein RH; Breuer R
Exp Lung Res; 1999 Sep; 25(6):531-41. PubMed ID: 10533678
[TBL] [Abstract][Full Text] [Related]
8. Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence.
Giri SN; Hyde DM
Am J Pathol; 1988 Dec; 133(3):525-36. PubMed ID: 2462354
[TBL] [Abstract][Full Text] [Related]
9. Effect of immunomodulators on bleomycin-induced lung injury.
Kremer S; Breuer R; Lossos IS; Berkman N; Christensen TG; Connor MW; Goldstein RH; Or R
Respiration; 1999; 66(5):455-62. PubMed ID: 10516543
[TBL] [Abstract][Full Text] [Related]
10. Abatement of bleomycin-induced pulmonary injury by cell-impermeable inhibitor of phospholipase A2.
Breuer R; Lossos IS; Or R; Krymsky M; Dagan A; Yedgar S
Life Sci; 1995; 57(16):PL237-40. PubMed ID: 7564888
[TBL] [Abstract][Full Text] [Related]
11. Time course of bleomycin-induced lung fibrosis.
Izbicki G; Segel MJ; Christensen TG; Conner MW; Breuer R
Int J Exp Pathol; 2002 Jun; 83(3):111-9. PubMed ID: 12383190
[TBL] [Abstract][Full Text] [Related]
12. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
13. Liposome encapsulation improves the effect of antifibrotic agent in rat lung fibrosis.
Poiani GJ; Greco M; Choe JK; Fox JD; Riley DJ
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1623-7. PubMed ID: 7524983
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of bleomycin-induced lung fibrosis by treatment with the platelet activating factor receptor antagonist WEB 2086 in hamsters.
Giri SN; Sharma AK; Hyde DM; Wild JS
Exp Lung Res; 1995; 21(2):287-307. PubMed ID: 7539741
[TBL] [Abstract][Full Text] [Related]
15. All-trans-retinoic acid (ATRA) is of no benefit in bleomycin-induced lung injury.
Segel MJ; Or R; Tzurel A; Lucey EC; Goldstein RH; Izbicki G; Breuer R
Pulm Pharmacol Ther; 2001; 14(5):403-7. PubMed ID: 11603953
[TBL] [Abstract][Full Text] [Related]
16. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.
Phin S; Marchand-Adam S; Fabre A; Marchal-Somme J; Bantsimba-Malanda C; Kataoka H; Soler P; Crestani B
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):286-93. PubMed ID: 19448157
[TBL] [Abstract][Full Text] [Related]
17. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
[TBL] [Abstract][Full Text] [Related]
18. Exercise Improves Lung Inflammation, but Not Lung Remodeling and Mechanics in a Model of Bleomycin-Induced Lung Fibrosis.
El-Mafarjeh E; Martins GHC; Probst JJ; Santos-Dias A; Oliveira-Junior MC; de Barros MP; de Oliveira LVF; de Andrade LD; da Palma RK; Moraes-Ferreira R; de Camargo Hizume-Kunzler D; Bachi ALL; Vieira RP
Oxid Med Cell Longev; 2020; 2020():4302608. PubMed ID: 33123311
[TBL] [Abstract][Full Text] [Related]
19. Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury.
Segel MJ; Aqeilan R; Zilka K; Lorberboum-Galski H; Wallach-Dayan SB; Conner MW; Christensen TG; Breuer R
Int J Exp Pathol; 2005 Oct; 86(5):279-88. PubMed ID: 16191100
[TBL] [Abstract][Full Text] [Related]
20. Bleomycin-induced lung fibrosis in IL-4-overexpressing and knockout mice.
Izbicki G; Or R; Christensen TG; Segel MJ; Fine A; Goldstein RH; Breuer R
Am J Physiol Lung Cell Mol Physiol; 2002 Nov; 283(5):L1110-6. PubMed ID: 12376365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
